Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Dec 19, 2013
Distillery Therapeutics
Indication: Infectious disease
...for licensing through UCL Business plc Contact: Abigail Watts, UCL Business plc, London, U.K. e-mail: a.watts@
uclb
.com...
Read More
BioCentury
|
Mar 15, 2012
Distillery Techniques
Technology: Markers
...Contact: Carol Harty, UCL Business plc, London, U.K. phone: +44 (0) 20 7679 9000 e-mail: c.harty@
uclb
.com...
Read More
BioCentury
|
Aug 1, 2011
Company News
March Medical Group, National Centre for Young People with Epilepsy, University College London deal
...subsidiary exclusive, worldwide rights to commercialize Epistatus buccal midazolam maleate to treat acute prolonged seizures.
UCLB
...
Read More
BioCentury
|
Jun 30, 2011
Distillery Techniques
Technology: Drug platforms
...Chris Williams, University College London Business plc, London, U.K. phone: +44 (0)20 7679 9000 e-mail: c.williams@
uclb
.com...
Read More
Items per page:
10
1 - 4 of 4
BioCentury
|
Dec 19, 2013
Distillery Therapeutics
Indication: Infectious disease
...for licensing through UCL Business plc Contact: Abigail Watts, UCL Business plc, London, U.K. e-mail: a.watts@
uclb
.com...
Read More
BioCentury
|
Mar 15, 2012
Distillery Techniques
Technology: Markers
...Contact: Carol Harty, UCL Business plc, London, U.K. phone: +44 (0) 20 7679 9000 e-mail: c.harty@
uclb
.com...
Read More
BioCentury
|
Aug 1, 2011
Company News
March Medical Group, National Centre for Young People with Epilepsy, University College London deal
...subsidiary exclusive, worldwide rights to commercialize Epistatus buccal midazolam maleate to treat acute prolonged seizures.
UCLB
...
Read More
BioCentury
|
Jun 30, 2011
Distillery Techniques
Technology: Drug platforms
...Chris Williams, University College London Business plc, London, U.K. phone: +44 (0)20 7679 9000 e-mail: c.williams@
uclb
.com...
Read More
Items per page:
10
1 - 4 of 4
Previous page
Next page